Dolby Laboratories Inc
NYSE:DLB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dolby Laboratories Inc
NYSE:DLB
|
US |
|
Ene Technology Inc
TWSE:6243
|
TW |
|
Celebrus Technologies PLC
LSE:CLBS
|
UK |
|
S
|
Sweet Poison Spirits Inc
CNSX:SPS
|
CA |
|
Frasers Hospitality Trust
SGX:ACV
|
SG |
|
C
|
Copperwired PCL
SET:CPW
|
TH |
|
A
|
Acme International Holdings Ltd
HKEX:1870
|
HK |
|
H
|
Humasis Co Ltd
KOSDAQ:205470
|
KR |
|
Morses Club PLC
LSE:MCL
|
UK |
|
PRT Company Ltd
ASX:PRT
|
AU |
Wall Street
Price Targets
DLB Price Targets Summary
Dolby Laboratories Inc
According to Wall Street analysts, the average 1-year price target for
DLB
is 89.58 USD
with a low forecast of 68.68 USD and a high forecast of 119.7 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DLB's stock price target?
Price Target
89.58
USD
According to Wall Street analysts, the average 1-year price target for
DLB
is 89.58 USD
with a low forecast of 68.68 USD and a high forecast of 119.7 USD.
What is Dolby Laboratories Inc's Revenue forecast?
Projected CAGR
5%
For the last 13 years the
compound annual growth rate for
Dolby Laboratories Inc's revenue is
3%.
The projected
CAGR
for the next 3 years is
5%.
What is Dolby Laboratories Inc's Operating Income forecast?
Projected CAGR
27%
For the last 13 years the
compound annual growth rate for
Dolby Laboratories Inc's operating income is
-2%.
The projected
CAGR
for the next 3 years is
27%.
What is Dolby Laboratories Inc's Net Income forecast?
Projected CAGR
7%
For the last 13 years the
compound annual growth rate for
Dolby Laboratories Inc's net income is
0%.
The projected
CAGR
for the next 3 years is
7%.
